Irisin in predicting major adverse cardiac events after myocardial infarction in obese hypertensive patients with type 2 diabetes mellitus

dc.contributor.authorShelest, Borys
dc.contributor.authorBabycheva, Oleksandra
dc.contributor.authorSadovenko, Olga
dc.contributor.authorKalmykov, Oleksii
dc.contributor.authorRodionova, Iulia
dc.contributor.authorAvdieienko, Oleksandra
dc.contributor.authorKovalova, Yuliia
dc.contributor.authorShelest, Oleksiy
dc.date.accessioned2025-11-17T13:06:33Z
dc.date.issued2025
dc.identifier.citationIrisin in predicting major adverse cardiac events after myocardial infarction in obese hypertensive patients with type 2 diabetes mellitus / B. Shelest, O. Babycheva, O. Sadovenko, O. Kalmykov, Iu. Rodionova, O. Avdieienko, Yu. Kovalova, O. Shelest // Journal of İstanbul Faculty of Medicine. – 2025. – Volume 88 (4). – P. 296–304.
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/36964
dc.language.isoen
dc.subject2025а
dc.titleIrisin in predicting major adverse cardiac events after myocardial infarction in obese hypertensive patients with type 2 diabetes mellitus
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ACAC257154544A899CC1094A8CAE00CB.pdf
Size:
312.32 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description: